1,368 results on '"Zucman-Rossi, Jessica"'
Search Results
2. Single-cell multiomics reveals the interplay of clonal evolution and cellular plasticity in hepatoblastoma
3. Author Correction: Hepatocellular carcinoma
4. Author Correction: A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinoma
5. Cellular and Molecular Techniques
6. List of Contributors
7. Predictive power of deleterious single amino acid changes to infer on AAV2 and AAV2-13 capsids fitness
8. Preneoplastic liver colonization by 11p15.5 altered mosaic cells in young children with hepatoblastoma
9. DLK1/DIO3 locus upregulation by a β-catenin-dependent enhancer drives cell proliferation and liver tumorigenesis
10. Mutational signature, cancer driver genes mutations and transcriptomic subgroups predict hepatoblastoma survival
11. Development of mutated β-catenin gene signature to identify CTNNB1 mutations from whole and spatial transcriptomic data in patients with HCC
12. Molecular-based targeted therapies in patients with hepatocellular carcinoma and hepato-cholangiocarcinoma refractory to atezolizumab/bevacizumab
13. Identification and experimental validation of druggable epigenetic targets in hepatoblastoma
14. Borderline Hepatocellular Adenomas: A Practical Diagnostic Approach Based on Pathologic and Molecular Features
15. RSK2 inactivation cooperates with AXIN1 inactivation or β-catenin activation to promote hepatocarcinogenesis
16. The exposome and liver disease - how environmental factors affect liver health
17. Integrating genetic variants into clinical models for hepatocellular carcinoma risk stratification in cirrhosis
18. Benign liver tumours: understanding molecular physiology to adapt clinical management
19. Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis
20. FRI-459 Outcome of targeting ATR in high replication stress murine HCC
21. TOP-552 Oncogenic beta-catenin is using CD155 as a molecular actor to corrupt immunosurveillance of cold HCC
22. Inhibiting Glutamine-Dependent mTORC1 Activation Ameliorates Liver Cancers Driven by β-Catenin Mutations
23. Bi-allelic hydroxymethylbilane synthase inactivation defines a homogenous clinico-molecular subtype of hepatocellular carcinoma
24. A framework for fibrolamellar carcinoma research and clinical trials
25. Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial
26. Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis
27. Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association study
28. cHCC‐CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation
29. Liver Cancer Initiation Requires p53 Inhibition by CD44-Enhanced Growth Factor Signaling
30. viroCapt: A Bioinformatics Pipeline for Identifying Viral Insertion in Human Host Genome
31. Molecular Subtypes and Gene Expression Signatures as Prognostic Features in Fully Resected Clear Cell Renal Cell Carcinoma: A Tailored Approach to Adjuvant Trials
32. The pro-oncogenic effect of the lncRNA H19 in the development of chronic inflammation-mediated hepatocellular carcinoma
33. Modeling a human hepatocellular carcinoma subset in mice through coexpression of met and point‐mutant β‐catenin
34. Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma
35. Hepatocellular carcinoma
36. Plk1, upregulated by HIF-2, mediates metastasis and drug resistance of clear cell renal cell carcinoma
37. Natural history of liver adenomatosis: A long-term observational study
38. A gp130–Src–YAP module links inflammation to epithelial regeneration
39. Clear-cell Renal Cell Carcinoma: Molecular Characterization of IMDC Risk Groups and Sarcomatoid Tumors
40. Hepatocellular Carcinomas With Mutational Activation of Beta-Catenin Require Choline and Can Be Detected by Positron Emission Tomography
41. Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response
42. Molecular and histological correlations in liver cancer
43. Dynamics and predicted drug response of a gene network linking dedifferentiation with beta-catenin dysfunction in hepatocellular carcinoma
44. Fibroblast Growth Factor Receptor-2 Polymorphism rs2981582 is Correlated With Progression-free Survival and Overall Survival in Patients With Metastatic Clear-cell Renal Cell Carcinoma Treated With Sunitinib
45. Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma
46. Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy
47. microRNA 193a-5p Regulates Levels of Nucleolar- and Spindle-Associated Protein 1 to Suppress Hepatocarcinogenesis
48. Dietary exacerbation of metabolic stress leads to accelerated hepatic carcinogenesis in glycogen storage disease type Ia
49. Polymorphisms in the Von Hippel–Lindau Gene Are Associated With Overall Survival in Metastatic Clear-Cell Renal-Cell Carcinoma Patients Treated With VEGFR Tyrosine Kinase Inhibitors
50. Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.